172 related articles for article (PubMed ID: 37326109)
1. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
Lu S; He T; Zhang Y; Zhou B; Zhang Q; Yan S
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326109
[TBL] [Abstract][Full Text] [Related]
2. Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
Wang X; Tan Y; Huang Z; Huang N; Gao M; Zhou F; Hu J; Feng W
Oncol Rep; 2019 Nov; 42(5):1755-1766. PubMed ID: 31432184
[TBL] [Abstract][Full Text] [Related]
3. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
4. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
6. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
[TBL] [Abstract][Full Text] [Related]
7. MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients.
Ramirez-Perez S; Vekariya R; Gautam S; Reyes-Perez IV; Drissi H; Bhattaram P
Arthritis Res Ther; 2023 Sep; 25(1):180. PubMed ID: 37749630
[TBL] [Abstract][Full Text] [Related]
8. Dinaciclib exerts a tumor-suppressing effect via β-catenin/YAP axis in pancreatic ductal adenocarcinoma.
Li Y; Zheng Z; Xiao L; Chen Y; Liu X; Long D; Chai L; Li Y; Tan C
Anticancer Drugs; 2024 Feb; 35(2):140-154. PubMed ID: 37694833
[TBL] [Abstract][Full Text] [Related]
9. MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88.
Song B; Zhang C; Li G; Jin G; Liu C
Cell Physiol Biochem; 2015; 35(3):1167-77. PubMed ID: 25766528
[TBL] [Abstract][Full Text] [Related]
10. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.
Chile T; Fortes MA; Corrêa-Giannella ML; Brentani HP; Maria DA; Puga RD; de Paula Vde J; Kubrusly MS; Novak EM; Bacchella T; Giorgi RR
BMC Cancer; 2013 Oct; 13():451. PubMed ID: 24088503
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
[TBL] [Abstract][Full Text] [Related]
12. Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825.
Liu M; Kang W; Hu Z; Wang C; Zhang Y
Inflamm Res; 2023 Nov; 72(10-11):2023-2036. PubMed ID: 37814128
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling.
Zhou X; Wang W; Li Z; Chen L; Wen C; Ruan Q; Xu Z; Liu R; Xu J; Bai Y; Deng J
Phytomedicine; 2022 Jan; 95():153861. PubMed ID: 34864627
[TBL] [Abstract][Full Text] [Related]
14. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
15. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
16. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
Karelia DN; Kim S; K Pandey M; Plano D; Amin S; Lu J; Sharma AK
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067020
[TBL] [Abstract][Full Text] [Related]
17. TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma.
Gu JF; Fu W; Qian HX; Gu WX; Zong Y; Chen Q; Lu L
World J Gastroenterol; 2020 Jul; 26(25):3586-3602. PubMed ID: 32742128
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
19. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
20. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]